Transenterix, inc

Transenterix, Inc. is a medical device company that specializes in the development and commercialization of robotic surgical systems. The company's flagship product, the Senhance™ Surgical Robotic System, is designed to enhance laparoscopic surgery through innovation.

The Senhance™ Surgical Robotic System is a state-of-the-art platform that enables surgeons to perform minimally invasive surgeries with greater precision and control. The system features advanced haptic feedback technology that provides surgeons with tactile feedback during procedures, allowing them to feel the tissue they are operating on.

One of the key advantages of the Senhance™ system is its ability to provide a more ergonomic working environment for surgeons. The system's console is designed to reduce physical strain on surgeons by allowing them to sit comfortably while performing procedures. This can help reduce fatigue and improve overall surgical outcomes.

In addition to its ergonomic design, the Senhance™ system also offers several other benefits over traditional laparoscopic surgery techniques. For example, it allows for greater range of motion and dexterity than traditional laparoscopic instruments, which can be particularly useful when operating in tight spaces or around delicate structures.

Another advantage of the Senhance™ system is its ability to integrate seamlessly with existing hospital infrastructure. The system uses standard 3mm or 5mm laparoscopic instruments and can be used with any standard OR table or boom arm.

Transenterix has been at the forefront of robotic surgery innovation since its inception in 2006. Over the years, it has developed a reputation for delivering cutting-edge technology that improves patient outcomes while reducing healthcare costs.

The company's commitment to innovation has been recognized by industry experts and investors alike. In 2017, Transenterix was named one of Fast Company's Most Innovative Companies in Robotics for its work on the Senhance™ Surgical Robotic System.

Today, Transenterix continues to push boundaries in robotic surgery through ongoing research and development efforts aimed at improving surgical outcomes even further. With a team of experienced engineers and medical professionals dedicated to advancing surgical robotics technology, Transenterix is poised for continued success well into the future.

In conclusion, Transenterix Inc.'s innovative approach towards advancing laparoscopic surgery through their flagship product -the Senhance™ Surgical Robotic System- has revolutionized how surgeries are performed today by providing greater precision & control along with an ergonomic design which reduces physical strain on surgeons leading towards better patient outcomes & reduced healthcare costs making it one-of-a-kind solution available today!